Literature DB >> 19300906

Processing of peptide and hormone precursors at the dibasic cleavage sites.

Mohamed Rholam1, Christine Fahy.   

Abstract

Many functionally important cellular peptides and proteins, including hormones, neuropeptides, and growth factors, are synthesized as inactive precursor polypeptides, which require post-translational proteolytic processing to become biologically active polypeptides. This is achieved by the action of a relatively small number of proteases that belong to a family of seven subtilisin-like proprotein convertases (PCs) including furin. In view of this, this review focuses on the importance of privileged secondary structures and of given amino acid residues around basic cleavage sites in substrate recognition by these endoproteases. In addition to their participation in normal cell functions, PCs are crucial for the initiation and progress of many important diseases. Hence, these proteases constitute potential drug targets in medicine. Accordingly, this review also discusses the approaches used to shed light on the cleavage preference and the substrate specificity of the PCs, a prerequisite to select which PCs are promising drug targets in each disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19300906     DOI: 10.1007/s00018-009-0007-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  113 in total

Review 1.  Inhibitors of the subtilase-like pro-protein convertases (SPCs).

Authors:  Martin Fugère; Robert Day
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

2.  Prosomatostatin is proteolytically processed at the amino terminal segment by subtilase SKI-1.

Authors:  R Mouchantaf; H L Watt; T Sulea; N G Seidah; H Alturaihi; Y C Patel; U Kumar
Journal:  Regul Pept       Date:  2004-08-15

3.  Prediction of neuropeptide prohormone cleavages with application to RFamides.

Authors:  Bruce R Southey; Sandra L Rodriguez-Zas; Jonathan V Sweedler
Journal:  Peptides       Date:  2006-02-21       Impact factor: 3.750

4.  Structural modeling of the pro-ocytocin-neurophysin precursor.

Authors:  B Velikson; P Cohen; M Rholam; J P Rose; B C Wang; J C Smith
Journal:  Protein Eng       Date:  1998-10

5.  Processing of rat preprocortistatin in mouse AtT-20 cells.

Authors:  L Puebla; R Mouchantaf; R Sasi; S Khare; H P Bennett; S James; Y C Patel
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

6.  Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation.

Authors:  Kristina Endres; Andreas Anders; Elzbieta Kojro; Sandra Gilbert; Falk Fahrenholz; Rolf Postina
Journal:  Eur J Biochem       Date:  2003-06

Review 7.  Regulation of prohormone convertases in hypothalamic neurons: implications for prothyrotropin-releasing hormone and proopiomelanocortin.

Authors:  Eduardo A Nillni
Journal:  Endocrinology       Date:  2007-06-21       Impact factor: 4.736

8.  The crystal structure of the proprotein processing proteinase furin explains its stringent specificity.

Authors:  Stefan Henrich; Angus Cameron; Gleb P Bourenkov; Reiner Kiefersauer; Robert Huber; Iris Lindberg; Wolfram Bode; Manuel E Than
Journal:  Nat Struct Biol       Date:  2003-07

9.  The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo.

Authors:  Miroslav S Sarac; Angus Cameron; Iris Lindberg
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.609

Review 10.  Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibition.

Authors:  Martin Fugère; Robert Day
Journal:  Trends Pharmacol Sci       Date:  2005-06       Impact factor: 14.819

View more
  26 in total

Review 1.  RALFs: peptide regulators of plant growth.

Authors:  Patricia A Bedinger; Gregory Pearce; Paul A Covey
Journal:  Plant Signal Behav       Date:  2010-11-01

2.  Ya-fish (Schizothorax prenanti) spexin: identification, tissue distribution and mRNA expression responses to periprandial and fasting.

Authors:  Hongwei Wu; Fangjun Lin; Hu Chen; Ju Liu; Yundi Gao; Xin Zhang; Jin Hao; Defang Chen; Dengyue Yuan; Tao Wang; Zhiqiong Li
Journal:  Fish Physiol Biochem       Date:  2015-08-27       Impact factor: 2.794

Review 3.  Biosynthesis of human myeloperoxidase.

Authors:  William M Nauseef
Journal:  Arch Biochem Biophys       Date:  2018-02-03       Impact factor: 4.013

4.  More than two decades of research on insect neuropeptide GPCRs: an overview.

Authors:  Jelle Caers; Heleen Verlinden; Sven Zels; Hans Peter Vandersmissen; Kristel Vuerinckx; Liliane Schoofs
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-30       Impact factor: 5.555

5.  Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph.

Authors:  Elias H Blanco; Juan R Peinado; Martín G Martín; Iris Lindberg
Journal:  Endocrinology       Date:  2014-06-16       Impact factor: 4.736

6.  Tomato Pistil Factor STIG1 Promotes in Vivo Pollen Tube Growth by Binding to Phosphatidylinositol 3-Phosphate and the Extracellular Domain of the Pollen Receptor Kinase LePRK2.

Authors:  Wei-Jie Huang; Hai-Kuan Liu; Sheila McCormick; Wei-Hua Tang
Journal:  Plant Cell       Date:  2014-06-17       Impact factor: 11.277

7.  Proconvertase proteolytic processing of an enzymatically active myeloperoxidase precursor.

Authors:  Sally McCormick; Angela Nelson; William M Nauseef
Journal:  Arch Biochem Biophys       Date:  2012-08-10       Impact factor: 4.013

8.  A large and accurate collection of peptidase cleavages in the MEROPS database.

Authors:  Neil D Rawlings
Journal:  Database (Oxford)       Date:  2009-11-02       Impact factor: 3.451

9.  Analysis of Thisbe and Pyramus functional domains reveals evidence for cleavage of Drosophila FGFs.

Authors:  Sarah Tulin; Angelike Stathopoulos
Journal:  BMC Dev Biol       Date:  2010-08-05       Impact factor: 1.978

10.  A novel enediynyl peptide inhibitor of furin that blocks processing of proPDGF-A, B and proVEGF-C.

Authors:  Ajoy Basak; Abdel-Majid Khatib; Dayani Mohottalage; Sarmistha Basak; Maria Kolajova; Subhendu Sekhar Bag; Amit Basak
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.